| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.667 | 0.005 | 0.667 | 5 Hydroxytryptamine release inhibitor | 0.634 0.007 CID_8375 | ||
| 0.619 | 0.005 | 0.619 | P-glycoprotein inhibitor | 0.506 0.008 CID_8375 | ||
| 0.586 | 0.011 | 0.637 | Histamine release inhibitor | 0.637 0.007 CID_8375 | CID_8375 | |
| 0.561 | 0.024 | 0.647 | Aldehyde oxidase inhibitor | 0.647 0.013 CID_8375 | CID_8375 | |
| 0.564 | 0.042 | 0.564 | Caspase 9 stimulant | 0.49 0.064 CID_8375 | ||
| 0.486 | 0.015 | 0.613 | Amyloid beta aggregation inhibitor | 0.613 0.007 CID_8375 | CID_8375 | |
| 0.491 | 0.029 | 0.494 | 5 Hydroxytryptamine release stimulant | 0.494 0.028 CID_8375 | CID_8375 | |
| 0.451 | 0.007 | 0.524 | 5 Hydroxytryptamine uptake stimulant | 0.524 0.004 CID_8375 | CID_8375 | |
| 0.473 | 0.034 | 0.473 | Vasodilator, peripheral | 0.448 0.041 CID_8375 | ||
| 0.434 | 0.005 | 0.434 | Breast cancer-resistant protein inhibitor | 0.234 0.01 CID_8375 | ||
| 0.446 | 0.019 | 0.556 | Superoxide dismutase inhibitor | 0.556 0.009 CID_8375 | CID_8375 | |
| 0.451 | 0.029 | 0.451 | Caspase 3 stimulant | 0.448 0.03 CID_8375 | ||
| 0.417 | 0.006 | 0.477 | Tyrosine 3 hydroxylase inhibitor | 0.477 0.004 CID_8375 | CID_8375 | |
| 0.406 | 0.006 | 0.406 | Tumour necrosis factor antagonist | 0.269 0.025 CID_8375 | ||
| 0.442 | 0.055 | 0.507 | Transcription factor NF kappa B inhibitor | 0.507 0.043 CID_8375 | CID_8375 | |
| 0.4 | 0.018 | 0.444 | Transcription factor STAT3 inhibitor | 0.444 0.012 CID_8375 | CID_8375 | |
| 0.412 | 0.031 | 0.412 | Vasodilator, coronary | 0.367 0.048 CID_8375 | ||
| 0.4 | 0.024 | 0.4 | Calcium channel activator | 0.357 0.045 CID_8375 | ||
| 0.4 | 0.03 | 0.426 | Hypoxia-inducible factor 1 alpha inhibitor | 0.426 0.024 CID_8375 | CID_8375 | |
| 0.391 | 0.021 | 0.461 | Transcription factor STAT inhibitor | 0.461 0.011 CID_8375 | CID_8375 | |
| 0.421 | 0.053 | 0.555 | GABA C receptor rho-3 antagonist | 0.555 0.014 CID_8375 | CID_8375 | |
| 0.351 | 0.005 | 0.351 | 3C-like protease (Human coronavirus) inhibitor | 0.286 0.015 CID_8375 | ||
| 0.441 | 0.095 | 0.503 | Apoptosis agonist | 0.503 0.073 CID_8375 | CID_8375 | |
| 0.373 | 0.034 | 0.538 | Free radical scavenger | 0.538 0.013 CID_8375 | CID_8375 | |
| 0.409 | 0.071 | 0.518 | 15-Lipoxygenase inhibitor | 0.518 0.037 CID_8375 | CID_8375 | |
| 0.418 | 0.085 | 0.418 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.414 0.089 CID_8375 | ||
| 0.372 | 0.045 | 0.471 | Lipoxygenase inhibitor | 0.471 0.023 CID_8375 | CID_8375 | |
| 0.386 | 0.063 | 0.428 | Thioredoxin glutathione reductase inhibitor | 0.428 0.047 CID_8375 | CID_8375 | |
| 0.35 | 0.028 | 0.526 | Peroxidase inhibitor | 0.526 0.008 CID_8375 | CID_8375 | |
| 0.327 | 0.007 | 0.327 | Nitric-oxide synthase stimulant | 0.32 0.008 CID_8375 | ||
| 0.367 | 0.05 | 0.49 | 12-Lipoxygenase inhibitor | 0.49 0.022 CID_8375 | CID_8375 | |
| 0.362 | 0.045 | 0.362 | Aryl hydrocarbon receptor agonist | 0.317 0.056 CID_8375 | ||
| 0.341 | 0.025 | 0.437 | Anesthetic general | 0.437 0.013 CID_8375 | CID_8375 | |
| 0.321 | 0.01 | 0.336 | NADPH oxidase inhibitor | 0.336 0.008 CID_8375 | CID_8375 | |
| 0.344 | 0.036 | 0.414 | Pyruvate kinase inhibitor | 0.414 0.018 CID_8375 | CID_8375 | |
| 0.38 | 0.072 | 0.38 | Calpain 2 inhibitor | 0.351 0.086 CID_8375 | ||
| 0.412 | 0.105 | 0.412 | Transcription factor inhibitor | 0.395 0.111 CID_8375 | ||
| 0.317 | 0.014 | 0.447 | Neurotrophic factor enhancer | 0.447 0.005 CID_8375 | CID_8375 | |
| 0.32 | 0.018 | 0.365 | MAO inhibitor | 0.365 0.014 CID_8375 | CID_8375 | |
| 0.306 | 0.005 | 0.359 | Farnesoid X receptor antagonist | 0.359 0.004 CID_8375 | CID_8375 | |
| 0.316 | 0.02 | 0.361 | Melanin inhibitor | 0.361 0.015 CID_8375 | CID_8375 | |
| 0.296 | 0.011 | 0.296 | Interleukin 1 antagonist | 0.228 0.024 CID_8375 | ||
| 0.338 | 0.054 | 0.382 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.382 0.042 CID_8375 | CID_8375 | |
| 0.285 | 0.007 | 0.346 | Mannose-6-phosphate isomerase inhibitor | 0.346 0.004 CID_8375 | CID_8375 | |
| 0.395 | 0.117 | 0.464 | Alpha-glucosidase inhibitor | 0.464 0.091 CID_8375 | CID_8375 | |
| 0.29 | 0.012 | 0.368 | Succinate dehydrogenase inhibitor | 0.368 0.005 CID_8375 | CID_8375 | |
| 0.289 | 0.02 | 0.289 | Tubulin antagonist | 0.146 0.06 CID_8375 | ||
| 0.299 | 0.034 | 0.307 | Gastrin inhibitor | 0.307 0.029 CID_8375 | CID_8375 | |
| 0.294 | 0.034 | 0.294 | 5 Hydroxytryptamine 1E antagonist | 0.265 0.058 CID_8375 | ||
| 0.315 | 0.056 | 0.508 | Antioxidant | 0.508 0.019 CID_8375 | CID_8375 | |
| 0.361 | 0.109 | 0.424 | Calcium channel L-type activator | 0.424 0.066 CID_8375 | CID_8375 | |
| 0.273 | 0.021 | 0.421 | Monophenol monooxygenase inhibitor | 0.421 0.01 CID_8375 | CID_8375 | |
| 0.379 | 0.128 | 0.379 | DNA polymerase beta inhibitor | 0.346 0.141 CID_8375 | ||
| 0.302 | 0.051 | 0.333 | Antiamyloidogenic | 0.333 0.043 CID_8375 | CID_8375 | |
| 0.285 | 0.035 | 0.39 | RNA-directed DNA polymerase inhibitor | 0.39 0.019 CID_8375 | CID_8375 | |
| 0.265 | 0.015 | 0.315 | MAO B inhibitor | 0.315 0.012 CID_8375 | CID_8375 | |
| 0.26 | 0.011 | 0.26 | Interleukin 1b antagonist | 0.139 0.048 CID_8375 | ||
| 0.297 | 0.054 | 0.297 | Tumour necrosis factor alpha release inhibitor | 0.207 0.103 CID_8375 | ||
| 0.26 | 0.025 | 0.34 | Amylase inhibitor | 0.34 0.014 CID_8375 | CID_8375 | |
| 0.317 | 0.086 | 0.341 | Thyroid hormone antagonist | 0.341 0.077 CID_8375 | CID_8375 | |
| 0.275 | 0.044 | 0.275 | Calpain inhibitor | 0.267 0.05 CID_8375 | ||
| 0.312 | 0.084 | 0.433 | Cholesterol antagonist | 0.433 0.043 CID_8375 | CID_8375 | |
| 0.23 | 0.002 | 0.23 | Granulocyte macrophage colony stimulating factor agonist | 0.201 0.003 CID_8375 | ||
| 0.266 | 0.04 | 0.266 | DNA methylase inhibitor | 0.26 0.043 CID_8375 | ||
| 0.228 | 0.003 | 0.228 | Potassium channel Kv1.3 blocker | 0.169 0.004 CID_8375 | ||
| 0.307 | 0.084 | 0.316 | Thyroid hormone beta antagonist | 0.316 0.08 CID_8375 | CID_8375 | |
| 0.302 | 0.084 | 0.354 | Apoptosis antagonist | 0.354 0.054 CID_8375 | CID_8375 | |
| 0.241 | 0.024 | 0.448 | Alpha-N-acetylglucosaminidase inhibitor | 0.448 0.007 CID_8375 | CID_8375 | |
| 0.242 | 0.027 | 0.469 | Phospholipase C inhibitor | 0.469 0.007 CID_8375 | CID_8375 | |
| 0.255 | 0.04 | 0.3 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.3 0.024 CID_8375 | CID_8375 | |
| 0.258 | 0.044 | 0.258 | DNA methyltransferase I inhibitor | 0.252 0.046 CID_8375 | ||
| 0.211 | 0.004 | 0.248 | Leukotriene D4 antagonist | 0.248 0.004 CID_8375 | CID_8375 | |
| 0.255 | 0.05 | 0.331 | Nitric oxide antagonist | 0.331 0.035 CID_8375 | CID_8375 | |
| 0.234 | 0.032 | 0.302 | Interferon gamma antagonist | 0.302 0.019 CID_8375 | CID_8375 | |
| 0.218 | 0.018 | 0.243 | Arachidonic acid antagonist | 0.243 0.007 CID_8375 | CID_8375 | |
| 0.275 | 0.075 | 0.334 | Insulysin inhibitor | 0.334 0.04 CID_8375 | CID_8375 | |
| 0.211 | 0.011 | 0.211 | Phosphodiesterase IV inhibitor | 0.074 0.068 CID_8375 | ||
| 0.229 | 0.03 | 0.27 | Phospholipase A2 inhibitor | 0.27 0.019 CID_8375 | CID_8375 | |
| 0.243 | 0.046 | 0.245 | Non-steroidal antiinflammatory agent | 0.245 0.045 CID_8375 | CID_8375 | |
| 0.219 | 0.026 | 0.251 | MAO A inhibitor | 0.251 0.021 CID_8375 | CID_8375 | |
| 0.337 | 0.145 | 0.337 | MAP kinase 1 inhibitor | 0.245 0.239 CID_8375 | ||
| 0.203 | 0.012 | 0.237 | Photosensitizer | 0.237 0.007 CID_8375 | CID_8375 | |
| 0.213 | 0.022 | 0.337 | 5-Lipoxygenase inhibitor | 0.337 0.008 CID_8375 | CID_8375 | |
| 0.335 | 0.145 | 0.34 | DNA directed DNA polymerase inhibitor | 0.34 0.143 CID_8375 | CID_8375 | |
| 0.199 | 0.012 | 0.267 | HIV-1 integrase (Overall Integration) inhibitor | 0.267 0.004 CID_8375 | CID_8375 | |
| 0.215 | 0.028 | 0.215 | Anesthetic local | 0.211 0.029 CID_8375 | ||
| 0.247 | 0.061 | 0.247 | Antimitotic | |||
| 0.209 | 0.024 | 0.215 | GABA C receptor rho-2 antagonist | 0.215 0.022 CID_8375 | CID_8375 | |
| 0.189 | 0.005 | 0.21 | Ca2+-transporting ATPase inhibitor | 0.21 0.003 CID_8375 | CID_8375 | |
| 0.205 | 0.023 | 0.331 | Cystathionine beta-synthase inhibitor | 0.331 0.007 CID_8375 | CID_8375 | |
| 0.265 | 0.085 | 0.296 | Spasmolytic | 0.296 0.072 CID_8375 | CID_8375 | |
| 0.218 | 0.039 | 0.323 | Heat shock protein 90 alpha antagonist | 0.323 0.011 CID_8375 | CID_8375 | |
| 0.189 | 0.015 | 0.189 | Calcium antagonist | 0.079 0.064 CID_8375 | ||
| 0.189 | 0.017 | 0.22 | Mediator release inhibitor | 0.22 0.012 CID_8375 | CID_8375 | |
| 0.282 | 0.11 | 0.335 | Prostaglandin dehydrogenase inhibitor | 0.335 0.088 CID_8375 | CID_8375 | |
| 0.204 | 0.032 | 0.204 | Acetylcholinesterase inhibitor | 0.144 0.059 CID_8375 | ||
| 0.188 | 0.017 | 0.27 | Potassium channel (Ca-activated) activator | 0.27 0.006 CID_8375 | CID_8375 | |
| 0.21 | 0.047 | 0.21 | 5 Hydroxytryptamine 3E antagonist | 0.208 0.05 CID_8375 | ||
| 0.187 | 0.024 | 0.187 | Cyclooxygenase 3 inhibitor | 0.162 0.039 CID_8375 | ||
| 0.17 | 0.008 | 0.17 | Acetylcholine release stimulant | 0.13 0.035 CID_8375 | ||
| 0.187 | 0.03 | 0.208 | Toll-Like receptor 2 antagonist | 0.208 0.02 CID_8375 | CID_8375 | |
| 0.177 | 0.02 | 0.177 | Vanilloid 1 agonist | 0.174 0.021 CID_8375 | ||
| 0.174 | 0.018 | 0.243 | Papain-like protease (SARS coronavirus) inhibitor | 0.243 0.005 CID_8375 | CID_8375 | |
| 0.293 | 0.137 | 0.293 | Beta lactamase inhibitor | |||
| 0.195 | 0.041 | 0.292 | Heat shock protein 90 antagonist | 0.292 0.011 CID_8375 | CID_8375 | |
| 0.25 | 0.103 | 0.444 | Streptokinase A inhibitor | 0.444 0.037 CID_8375 | CID_8375 | |
| 0.196 | 0.05 | 0.196 | Cytidine deaminase inhibitor | 0.168 0.063 CID_8375 | ||
| 0.166 | 0.022 | 0.23 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.23 0.012 CID_8375 | CID_8375 | |
| 0.226 | 0.082 | 0.226 | Neuropeptide Y2 antagonist | 0.226 0.082 CID_8375 | ||
| 0.177 | 0.033 | 0.224 | Cholesterol synthesis inhibitor | 0.224 0.022 CID_8375 | CID_8375 | |
| 0.175 | 0.032 | 0.175 | Cathepsin H inhibitor | 0.174 0.032 CID_8375 | ||
| 0.171 | 0.028 | 0.171 | Microtubule formation inhibitor | 0.162 0.032 CID_8375 | ||
| 0.163 | 0.02 | 0.241 | Beta glucuronidase inhibitor | 0.241 0.009 CID_8375 | CID_8375 | |
| 0.179 | 0.038 | 0.215 | Neurotrophic factor | 0.215 0.021 CID_8375 | CID_8375 | |
| 0.149 | 0.008 | 0.195 | Bile acid receptor antagonist | 0.195 0.004 CID_8375 | CID_8375 | |
| 0.198 | 0.058 | 0.238 | Lipocortins synthesis antagonist | 0.238 0.038 CID_8375 | CID_8375 | |
| 0.165 | 0.024 | 0.379 | UDP-glucose 4-epimerase inhibitor | 0.379 0.007 CID_8375 | CID_8375 | |
| 0.164 | 0.025 | 0.171 | Mucolytic | 0.171 0.022 CID_8375 | CID_8375 | |
| 0.169 | 0.033 | 0.169 | Antibacterial (Helicobacter pylori) | 0.155 0.042 CID_8375 | ||
| 0.226 | 0.092 | 0.285 | Hypoglycemic | 0.285 0.058 CID_8375 | CID_8375 | |
| 0.175 | 0.041 | 0.196 | CF transmembrane conductance regulator agonist | 0.196 0.024 CID_8375 | CID_8375 | |
| 0.14 | 0.007 | 0.223 | D-Ala-D-Ala ligase inhibitor | 0.223 0.003 CID_8375 | CID_8375 | |
| 0.141 | 0.011 | 0.168 | Leukotriene antagonist | 0.168 0.008 CID_8375 | CID_8375 | |
| 0.18 | 0.05 | 0.212 | Protein kinase stimulant | 0.212 0.037 CID_8375 | CID_8375 | |
| 0.174 | 0.045 | 0.189 | Alkaline phosphatase inhibitor | 0.189 0.038 CID_8375 | CID_8375 | |
| 0.138 | 0.009 | 0.15 | Glycine receptor agonist | 0.15 0.007 CID_8375 | CID_8375 | |
| 0.154 | 0.025 | 0.154 | Gastric antisecretory | 0.111 0.052 CID_8375 | ||
| 0.133 | 0.005 | 0.146 | GABA B receptor agonist | 0.146 0.004 CID_8375 | CID_8375 | |
| 0.15 | 0.024 | 0.15 | Sphingomyelinase inhibitor | 0.112 0.048 CID_8375 | ||
| 0.143 | 0.017 | 0.194 | Macrophage migration inhibitory factor inhibitor | 0.194 0.008 CID_8375 | CID_8375 | |
| 0.136 | 0.014 | 0.136 | Glutamate release inhibitor | 0.121 0.021 CID_8375 | ||
| 0.222 | 0.101 | 0.281 | Interleukin agonist | 0.281 0.058 CID_8375 | CID_8375 | |
| 0.139 | 0.019 | 0.139 | CYP2A6 inhibitor | 0.122 0.026 CID_8375 | ||
| 0.151 | 0.034 | 0.151 | Butyrylcholinesterase inhibitor | 0.098 0.063 CID_8375 | ||
| 0.149 | 0.032 | 0.169 | TRPA1 agonist | 0.169 0.02 CID_8375 | CID_8375 | |
| 0.139 | 0.022 | 0.189 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.189 0.011 CID_8375 | CID_8375 | |
| 0.148 | 0.036 | 0.151 | Expectorant | 0.151 0.035 CID_8375 | CID_8375 | |
| 0.156 | 0.044 | 0.247 | Aldehyde dehydrogenase inhibitor | 0.247 0.018 CID_8375 | CID_8375 | |
| 0.134 | 0.023 | 0.134 | Phosphodiesterase 4D inhibitor | |||
| 0.13 | 0.019 | 0.177 | Ornithine decarboxylase inhibitor | 0.177 0.006 CID_8375 | CID_8375 | |
| 0.171 | 0.06 | 0.182 | Neurotensin receptor agonist | 0.182 0.048 CID_8375 | CID_8375 | |
| 0.115 | 0.005 | 0.115 | Glutamate (mGluR7) antagonist | 0.09 0.018 CID_8375 | ||
| 0.143 | 0.033 | 0.176 | Carbonic anhydrase XV inhibitor | 0.176 0.023 CID_8375 | CID_8375 | |
| 0.13 | 0.022 | 0.13 | Glutamate (mGluR7) agonist | 0.091 0.08 CID_8375 | ||
| 0.192 | 0.085 | 0.192 | Psychostimulant | 0.147 0.118 CID_8375 | ||
| 0.194 | 0.087 | 0.269 | Interleukin antagonist | 0.269 0.055 CID_8375 | CID_8375 | |
| 0.119 | 0.012 | 0.196 | Purinergic P2X1 antagonist | 0.196 0.004 CID_8375 | CID_8375 | |
| 0.19 | 0.084 | 0.204 | Insulin sensitizer | 0.204 0.07 CID_8375 | CID_8375 | |
| 0.136 | 0.03 | 0.136 | Electron transport complex I inhibitor | |||
| 0.136 | 0.03 | 0.22 | DOPA decarboxylase inhibitor | 0.22 0.005 CID_8375 | CID_8375 | |
| 0.15 | 0.046 | 0.16 | Heat shock protein 70 antagonist | 0.16 0.028 CID_8375 | CID_8375 | |
| 0.113 | 0.01 | 0.113 | Potassium channel (ATP-sensitive) blocker | 0.082 0.026 CID_8375 | ||
| 0.188 | 0.087 | 0.202 | Histone acetyltransferase inhibitor | 0.202 0.066 CID_8375 | CID_8375 | |
| 0.114 | 0.013 | 0.14 | Estrogen-related receptor beta agonist | 0.14 0.005 CID_8375 | CID_8375 | |
| 0.115 | 0.015 | 0.365 | Alcohol oxidase inhibitor | 0.365 0.004 CID_8375 | CID_8375 | |
| 0.128 | 0.03 | 0.191 | Androgen antagonist | 0.191 0.014 CID_8375 | CID_8375 | |
| 0.117 | 0.02 | 0.117 | Phosphodiesterase 5A inhibitor | 0.088 0.033 CID_8375 | ||
| 0.141 | 0.045 | 0.141 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.106 | 0.009 | 0.128 | Leukotriene B4 antagonist | 0.128 0.006 CID_8375 | CID_8375 | |
| 0.199 | 0.106 | 0.199 | Vasodilator | 0.192 0.111 CID_8375 | ||
| 0.113 | 0.022 | 0.113 | Phosphodiesterase V inhibitor | 0.084 0.038 CID_8375 | ||
| 0.135 | 0.045 | 0.246 | Ferrochelatase inhibitor | 0.246 0.014 CID_8375 | CID_8375 | |
| 0.148 | 0.058 | 0.195 | Cyclooxygenase 1 inhibitor | 0.195 0.037 CID_8375 | CID_8375 | |
| 0.134 | 0.045 | 0.145 | Falcipain 3 inhibitor | 0.145 0.039 CID_8375 | CID_8375 | |
| 0.234 | 0.146 | 0.343 | Sodium/bile acid cotransporter inhibitor | 0.343 0.044 CID_8375 | CID_8375 | |
| 0.159 | 0.07 | 0.223 | Diuretic | 0.223 0.036 CID_8375 | CID_8375 | |
| 0.123 | 0.036 | 0.153 | Prolactin inhibitor | 0.153 0.021 CID_8375 | CID_8375 | |
| 0.126 | 0.039 | 0.14 | Urease inhibitor | 0.14 0.029 CID_8375 | CID_8375 | |
| 0.15 | 0.063 | 0.193 | Adenylate cyclase stimulant | 0.193 0.017 CID_8375 | CID_8375 | |
| 0.094 | 0.008 | 0.094 | 5 Hydroxytryptamine 7 agonist | 0.064 0.026 CID_8375 | ||
| 0.129 | 0.043 | 0.18 | Xanthine oxidase inhibitor | 0.18 0.024 CID_8375 | CID_8375 | |
| 0.093 | 0.007 | 0.093 | Calcium channel P-type blocker | 0.061 0.056 CID_8375 | ||
| 0.142 | 0.057 | 0.249 | Interleukin 4 antagonist | 0.249 0.013 CID_8375 | CID_8375 | |
| 0.123 | 0.039 | 0.264 | Creatine kinase inhibitor | 0.264 0.005 CID_8375 | CID_8375 | |
| 0.105 | 0.021 | 0.105 | Beta tubulin antagonist | 0.083 0.028 CID_8375 | ||
| 0.118 | 0.034 | 0.204 | Triose-phosphate isomerase inhibitor | 0.204 0.01 CID_8375 | CID_8375 | |
| 0.115 | 0.031 | 0.17 | NADH dehydrogenase inhibitor | 0.17 0.014 CID_8375 | CID_8375 | |
| 0.156 | 0.072 | 0.156 | Cholinergic | |||
| 0.095 | 0.011 | 0.233 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.233 0.003 CID_8375 | CID_8375 | |
| 0.088 | 0.005 | 0.088 | Ryanodine receptor antagonist | 0.071 0.016 CID_8375 | ||
| 0.134 | 0.051 | 0.135 | Sphingosine 1-phosphate receptor 4 antagonist | 0.135 0.049 CID_8375 | CID_8375 | |
| 0.181 | 0.098 | 0.181 | Anticonvulsant | 0.173 0.105 CID_8375 | ||
| 0.199 | 0.116 | 0.205 | DNA damaging | 0.205 0.111 CID_8375 | CID_8375 | |
| 0.108 | 0.026 | 0.169 | Keratolytic | 0.169 0.012 CID_8375 | CID_8375 | |
| 0.089 | 0.008 | 0.089 | Glutamate (mGluR group II) agonist | 0.087 0.008 CID_8375 | ||
| 0.093 | 0.012 | 0.097 | Phosphodiesterase 1C inhibitor | 0.097 0.011 CID_8375 | CID_8375 | |
| 0.093 | 0.013 | 0.093 | Exportin-1 inhibitor | 0.073 0.036 CID_8375 | ||
| 0.103 | 0.023 | 0.103 | Calcium channel L-type blocker | 0.072 0.05 CID_8375 | ||
| 0.087 | 0.008 | 0.087 | Glutamate (mGluR2) agonist | 0.082 0.008 CID_8375 | ||
| 0.153 | 0.075 | 0.212 | Hexokinase inhibitor | 0.212 0.029 CID_8375 | CID_8375 | |
| 0.131 | 0.053 | 0.137 | DNA repair enzyme inhibitor | 0.137 0.045 CID_8375 | CID_8375 | |
| 0.119 | 0.041 | 0.145 | GABA C receptor rho-1 antagonist | 0.145 0.023 CID_8375 | CID_8375 | |
| 0.184 | 0.107 | 0.184 | Cyclic AMP phosphodiesterase inhibitor | 0.181 0.11 CID_8375 | ||
| 0.088 | 0.011 | 0.088 | Transcription factor RelA inhibitor | 0.077 0.02 CID_8375 | ||
| 0.145 | 0.07 | 0.16 | Sphingosine 1-phosphate receptor 5 antagonist | 0.16 0.047 CID_8375 | CID_8375 | |
| 0.08 | 0.008 | 0.097 | Leukotriene C antagonist | 0.097 0.004 CID_8375 | CID_8375 | |
| 0.086 | 0.014 | 0.086 | Potassium channel intermediate-conductance Ca-activated blocker | 0.063 0.037 CID_8375 | ||
| 0.09 | 0.019 | 0.09 | Aryl hydrocarbon receptor antagonist | 0.071 0.037 CID_8375 | ||
| 0.104 | 0.033 | 0.104 | Inducible nitric-oxide synthase inhibitor | 0.096 0.041 CID_8375 | ||
| 0.125 | 0.053 | 0.143 | Caspase 3 inhibitor | 0.143 0.033 CID_8375 | CID_8375 | |
| 0.076 | 0.005 | 0.076 | Benzodiazepine antagonist | 0.045 0.04 CID_8375 | ||
| 0.089 | 0.018 | 0.089 | Phosphodiesterase 1B inhibitor | 0.077 0.025 CID_8375 | ||
| 0.198 | 0.127 | 0.256 | DNA synthesis inhibitor | 0.256 0.062 CID_8375 | CID_8375 | |
| 0.106 | 0.035 | 0.126 | Carbonic anhydrase XIII inhibitor | 0.126 0.028 CID_8375 | CID_8375 | |
| 0.135 | 0.064 | 0.143 | Sphingosine 1-phosphate receptor 2 antagonist | 0.143 0.05 CID_8375 | CID_8375 | |
| 0.099 | 0.028 | 0.099 | Peroxisome proliferator-activated receptor gamma agonist | 0.089 0.034 CID_8375 | ||
| 0.123 | 0.054 | 0.17 | Transcription factor STAT6 inhibitor | 0.17 0.013 CID_8375 | CID_8375 | |
| 0.095 | 0.028 | 0.096 | Sphingosine 1-phosphate receptor 4 agonist | 0.096 0.027 CID_8375 | CID_8375 | |
| 0.138 | 0.071 | 0.138 | Toll-Like receptor 9 antagonist | |||
| 0.07 | 0.004 | 0.093 | Leukotriene B4 receptor 1 antagonist | 0.093 0.004 CID_8375 | CID_8375 | |
| 0.104 | 0.039 | 0.104 | Phosphodiesterase I inhibitor | 0.097 0.049 CID_8375 | ||
| 0.082 | 0.017 | 0.082 | Cyclin D1 inhibitor | 0.065 0.035 CID_8375 | ||
| 0.098 | 0.034 | 0.098 | Cathepsin G inhibitor | 0.098 0.034 CID_8375 | ||
| 0.09 | 0.026 | 0.09 | Acetylcholine M5 receptor agonist | |||
| 0.068 | 0.004 | 0.068 | Vanilloid 3 antagonist | 0.054 0.006 CID_8375 | ||
| 0.113 | 0.05 | 0.17 | Adenylate kinase inhibitor | 0.17 0.02 CID_8375 | CID_8375 | |
| 0.159 | 0.097 | 0.189 | Platelet adhesion inhibitor | 0.189 0.077 CID_8375 | CID_8375 | |
| 0.155 | 0.093 | 0.17 | ATPase inhibitor | 0.17 0.071 CID_8375 | CID_8375 | |
| 0.112 | 0.05 | 0.172 | Carbonic anhydrase III inhibitor | 0.172 0.022 CID_8375 | CID_8375 | |
| 0.08 | 0.018 | 0.084 | Beta 1 adrenoreceptor antagonist | 0.084 0.016 CID_8375 | CID_8375 | |
| 0.098 | 0.037 | 0.098 | Histamine H2 receptor antagonist | 0.084 0.057 CID_8375 | ||
| 0.068 | 0.007 | 0.068 | Potassium channel Kv1.1 blocker | 0.052 0.012 CID_8375 | ||
| 0.084 | 0.024 | 0.085 | Protease 3C (Human rhinovirus) inhibitor | 0.085 0.024 CID_8375 | CID_8375 | |
| 0.093 | 0.034 | 0.187 | Glutamate decarboxylase inhibitor | 0.187 0.008 CID_8375 | CID_8375 | |
| 0.113 | 0.054 | 0.248 | GABA C receptor agonist | 0.248 0.014 CID_8375 | CID_8375 | |
| 0.083 | 0.025 | 0.094 | Beta adrenoreceptor antagonist | 0.094 0.019 CID_8375 | CID_8375 | |
| 0.216 | 0.158 | 0.232 | Antithrombotic | 0.232 0.141 CID_8375 | CID_8375 | |
| 0.107 | 0.049 | 0.151 | Electrolyte absorption antagonist | 0.151 0.019 CID_8375 | CID_8375 | |
| 0.078 | 0.021 | 0.078 | Phosphodiesterase 4A inhibitor | |||
| 0.091 | 0.034 | 0.123 | GABA aminotransferase inhibitor | 0.123 0.015 CID_8375 | CID_8375 | |
| 0.093 | 0.037 | 0.093 | Caspase 7 inhibitor | 0.079 0.064 CID_8375 | ||
| 0.081 | 0.025 | 0.081 | Potassium channel Kv1.5 blocker | |||
| 0.083 | 0.028 | 0.083 | Potassium channel (Tandem pore domain) blocker | |||
| 0.063 | 0.009 | 0.064 | Guanylate cyclase inhibitor | 0.064 0.008 CID_8375 | CID_8375 | |
| 0.072 | 0.017 | 0.093 | Aconitate hydratase inhibitor | 0.093 0.01 CID_8375 | CID_8375 | |
| 0.096 | 0.041 | 0.117 | Glutathione S-transferase inhibitor | 0.117 0.024 CID_8375 | CID_8375 | |
| 0.107 | 0.053 | 0.148 | Anabolic | 0.148 0.019 CID_8375 | CID_8375 | |
| 0.136 | 0.082 | 0.149 | Cyclooxygenase inhibitor | 0.149 0.07 CID_8375 | CID_8375 | |
| 0.133 | 0.081 | 0.286 | Lipid peroxidase inhibitor | 0.286 0.021 CID_8375 | CID_8375 | |
| 0.113 | 0.06 | 0.172 | GABA C receptor antagonist | 0.172 0.02 CID_8375 | CID_8375 | |
| 0.068 | 0.016 | 0.167 | Estradiol 17 beta-dehydrogenase inhibitor | 0.167 0.005 CID_8375 | CID_8375 | |
| 0.067 | 0.017 | 0.068 | Pregnane X receptor antagonist | 0.068 0.016 CID_8375 | CID_8375 | |
| 0.056 | 0.006 | 0.056 | Melatonin receptor 1A agonist | |||
| 0.06 | 0.01 | 0.078 | GABA uptake inhibitor | 0.078 0.005 CID_8375 | CID_8375 | |
| 0.066 | 0.016 | 0.066 | Aldosterone antagonist | 0.061 0.019 CID_8375 | ||
| 0.09 | 0.041 | 0.413 | Porphobilinogen synthase inhibitor | 0.413 0.004 CID_8375 | CID_8375 | |
| 0.238 | 0.189 | 0.374 | Antibacterial | 0.374 0.089 CID_8375 | CID_8375 | |
| 0.076 | 0.027 | 0.115 | Xanthine dehydrogenase inhibitor | 0.115 0.012 CID_8375 | CID_8375 | |
| 0.103 | 0.054 | 0.103 | Nitric-oxide synthase inhibitor | 0.098 0.064 CID_8375 | ||
| 0.102 | 0.053 | 0.116 | Lanosterol 14 alpha demethylase inhibitor | 0.116 0.035 CID_8375 | CID_8375 | |
| 0.112 | 0.064 | 0.112 | Alpha 2b adrenoreceptor antagonist | |||
| 0.077 | 0.03 | 0.077 | 5 Hydroxytryptamine 2A agonist | |||
| 0.055 | 0.008 | 0.055 | Heme oxygenase inhibitor | 0.054 0.009 CID_8375 | ||
| 0.162 | 0.115 | 0.281 | Angiogenesis stimulant | 0.281 0.057 CID_8375 | CID_8375 | |
| 0.055 | 0.008 | 0.071 | Leukotriene C4 antagonist | 0.071 0.004 CID_8375 | CID_8375 | |
| 0.091 | 0.044 | 0.1 | Glutamate receptor agonist | 0.1 0.037 CID_8375 | CID_8375 | |
| 0.099 | 0.052 | 0.099 | Toll-Like receptor 3 antagonist | |||
| 0.058 | 0.012 | 0.058 | Glutamate (mGluR group II) antagonist | 0.046 0.019 CID_8375 | ||
| 0.067 | 0.02 | 0.107 | Dihydroorotate oxidase inhibitor | 0.107 0.004 CID_8375 | CID_8375 | |
| 0.116 | 0.071 | 0.134 | Alkylator | 0.134 0.056 CID_8375 | CID_8375 | |
| 0.173 | 0.128 | 0.173 | ErbB-1 antagonist | |||
| 0.089 | 0.044 | 0.125 | Glycine receptor antagonist | 0.125 0.015 CID_8375 | CID_8375 | |
| 0.115 | 0.07 | 0.137 | Proteasome inhibitor | 0.137 0.054 CID_8375 | CID_8375 | |
| 0.123 | 0.079 | 0.123 | Phosphodiesterase inhibitor | |||
| 0.054 | 0.011 | 0.072 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.072 0.004 CID_8375 | CID_8375 | |
| 0.073 | 0.03 | 0.081 | Beta 3 adrenoreceptor antagonist | 0.081 0.023 CID_8375 | CID_8375 | |
| 0.093 | 0.05 | 0.093 | Bromodomain-containing protein 2 inhibitor | |||
| 0.086 | 0.044 | 0.124 | Catalase inhibitor | 0.124 0.032 CID_8375 | CID_8375 | |
| 0.063 | 0.021 | 0.063 | Prolyl endopeptidase inhibitor | 0.061 0.023 CID_8375 | ||
| 0.062 | 0.021 | 0.063 | Immunoglobulin Fc receptor antagonist | 0.063 0.019 CID_8375 | CID_8375 | |
| 0.079 | 0.038 | 0.097 | Carbonic anhydrase VA inhibitor | 0.097 0.026 CID_8375 | CID_8375 | |
| 0.104 | 0.064 | 0.104 | Toll-Like receptor 4 antagonist | 0.103 0.065 CID_8375 | ||
| 0.063 | 0.023 | 0.089 | Adenine nucleotide translocase inhibitor | 0.089 0.006 CID_8375 | CID_8375 | |
| 0.091 | 0.052 | 0.091 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.092 | 0.053 | 0.14 | Histamine N-methyltransferase inhibitor | 0.14 0.018 CID_8375 | CID_8375 | |
| 0.096 | 0.057 | 0.197 | Alcohol dehydrogenase inhibitor | 0.197 0.013 CID_8375 | CID_8375 | |
| 0.149 | 0.111 | 0.187 | Hepatoprotectant | 0.187 0.074 CID_8375 | CID_8375 | |
| 0.072 | 0.035 | 0.086 | Glutamate (mGluR6) antagonist | 0.086 0.018 CID_8375 | CID_8375 | |
| 0.084 | 0.046 | 0.084 | Nicotinic alpha4beta2 receptor antagonist | 0.071 0.06 CID_8375 | ||
| 0.061 | 0.023 | 0.061 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.041 | 0.005 | 0.052 | Leukotriene B4 receptor 2 antagonist | 0.052 0.004 CID_8375 | CID_8375 | |
| 0.059 | 0.023 | 0.059 | Alpha 1L adrenoreceptor antagonist | |||
| 0.075 | 0.039 | 0.175 | Potassium channel large-conductance Ca-activated activator | 0.175 0.008 CID_8375 | CID_8375 | |
| 0.079 | 0.043 | 0.227 | Histidine decarboxylase inhibitor | 0.227 0.01 CID_8375 | CID_8375 | |
| 0.043 | 0.008 | 0.054 | Glutamate (mGluR3) agonist | 0.054 0.004 CID_8375 | CID_8375 | |
| 0.068 | 0.033 | 0.073 | Transcription factor AP-1 inhibitor | 0.073 0.027 CID_8375 | CID_8375 | |
| 0.085 | 0.05 | 0.085 | Thioredoxin reductase inhibitor | 0.083 0.054 CID_8375 | ||
| 0.076 | 0.041 | 0.076 | Peroxisome proliferator-activated receptor gamma antagonist | 0.074 0.044 CID_8375 | ||
| 0.087 | 0.053 | 0.089 | mTOR complex 2 inhibitor | 0.089 0.05 CID_8375 | CID_8375 | |
| 0.082 | 0.048 | 0.102 | Na+ K+ transporting ATPase inhibitor | 0.102 0.029 CID_8375 | CID_8375 | |
| 0.048 | 0.016 | 0.048 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.058 | 0.026 | 0.061 | Glucose-6-phosphate translocase inhibitor | 0.061 0.023 CID_8375 | CID_8375 | |
| 0.074 | 0.041 | 0.118 | Leukotriene synthesis inhibitor | 0.118 0.017 CID_8375 | CID_8375 | |
| 0.073 | 0.04 | 0.097 | Carbonic anhydrase V inhibitor | 0.097 0.028 CID_8375 | CID_8375 | |
| 0.043 | 0.01 | 0.043 | Glutamate (mGluR2) antagonist | 0.03 0.02 CID_8375 | ||
| 0.123 | 0.092 | 0.123 | Activin receptor-like kinase 2 inhibitor | |||
| 0.061 | 0.03 | 0.061 | Alpha tubulin antagonist | 0.056 0.034 CID_8375 | ||
| 0.058 | 0.027 | 0.058 | Peroxisome proliferator-activated receptor alpha agonist | 0.043 0.039 CID_8375 | ||
| 0.109 | 0.079 | 0.109 | Beta amyloid protein antagonist | |||
| 0.049 | 0.019 | 0.049 | Dihydrofolate reductase inhibitor | |||
| 0.048 | 0.019 | 0.05 | Progesterone antagonist | 0.05 0.018 CID_8375 | CID_8375 | |
| 0.047 | 0.018 | 0.052 | Kainate receptor agonist | 0.052 0.012 CID_8375 | CID_8375 | |
| 0.077 | 0.047 | 0.077 | Phosphodiesterase VI inhibitor | |||
| 0.035 | 0.006 | 0.035 | Hedgehog signaling activator | 0.028 0.016 CID_8375 | ||
| 0.042 | 0.013 | 0.042 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.051 | 0.023 | 0.051 | Leukocyte elastase inhibitor | |||
| 0.042 | 0.014 | 0.042 | Carnitine palmitoyltransferase inhibitor | |||
| 0.045 | 0.017 | 0.056 | Retinoid X receptor antagonist | 0.056 0.008 CID_8375 | CID_8375 | |
| 0.069 | 0.041 | 0.074 | MDM2 inhibitor | 0.074 0.029 CID_8375 | CID_8375 | |
| 0.072 | 0.044 | 0.072 | Elastase 1 inhibitor | 0.066 0.052 CID_8375 | ||
| 0.063 | 0.035 | 0.133 | Argininosuccinate synthase inhibitor | 0.133 0.013 CID_8375 | CID_8375 | |
| 0.078 | 0.051 | 0.104 | MAP kinase kinase 7 inhibitor | 0.104 0.01 CID_8375 | CID_8375 | |
| 0.153 | 0.126 | 0.153 | Focal adhesion kinase 2 inhibitor | |||
| 0.075 | 0.048 | 0.079 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.079 0.039 CID_8375 | CID_8375 | |
| 0.047 | 0.02 | 0.047 | Plasmepsin II inhibitor | |||
| 0.04 | 0.014 | 0.04 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.129 | 0.103 | 0.129 | Neuropeptide Y1 antagonist | |||
| 0.039 | 0.013 | 0.039 | Adenosine uptake inhibitor | 0.035 0.025 CID_8375 | ||
| 0.051 | 0.025 | 0.051 | CC chemokine 4 receptor antagonist | |||
| 0.121 | 0.095 | 0.121 | Nav1.6 sodium channel blocker | |||
| 0.029 | 0.004 | 0.031 | Antibiotic Anthracycline-like | 0.031 0.004 CID_8375 | CID_8375 | |
| 0.117 | 0.092 | 0.117 | Cytokine production inhibitor | |||
| 0.101 | 0.076 | 0.111 | GABA receptor agonist | 0.111 0.065 CID_8375 | CID_8375 | |
| 0.055 | 0.03 | 0.055 | H+/K+-transporting ATPase inhibitor | |||
| 0.062 | 0.037 | 0.062 | Phosphodiesterase 1A inhibitor | 0.057 0.049 CID_8375 | ||
| 0.039 | 0.016 | 0.047 | Retinoid X alpha receptor antagonist | 0.047 0.008 CID_8375 | CID_8375 | |
| 0.029 | 0.005 | 0.033 | Alpha 2a adrenoreceptor agonist | 0.033 0.005 CID_8375 | CID_8375 | |
| 0.077 | 0.054 | 0.138 | Estrogen receptor alpha antagonist | 0.138 0.014 CID_8375 | CID_8375 | |
| 0.053 | 0.03 | 0.053 | Potassium channel (Inward rectifier) blocker | |||
| 0.033 | 0.01 | 0.113 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.113 0.004 CID_8375 | CID_8375 | |
| 0.027 | 0.004 | 0.027 | Complement factor D inhibitor | 0.019 0.011 CID_8375 | ||
| 0.088 | 0.066 | 0.088 | Polo-like kinase-1 inhibitor | |||
| 0.04 | 0.018 | 0.083 | Sirtuin 2 inhibitor | 0.083 0.005 CID_8375 | CID_8375 | |
| 0.062 | 0.04 | 0.082 | Aromatase inhibitor | 0.082 0.026 CID_8375 | CID_8375 | |
| 0.06 | 0.039 | 0.069 | Sphingosine 1-phosphate receptor 3 antagonist | 0.069 0.027 CID_8375 | CID_8375 | |
| 0.045 | 0.024 | 0.047 | Liver X receptor alpha agonist | 0.047 0.021 CID_8375 | CID_8375 | |
| 0.061 | 0.041 | 0.216 | HIV-1 integrase (Strand Transfer) inhibitor | 0.216 0.008 CID_8375 | CID_8375 | |
| 0.052 | 0.032 | 0.053 | Lysophosphatidic acid 3 receptor antagonist | 0.053 0.031 CID_8375 | CID_8375 | |
| 0.037 | 0.017 | 0.037 | Melatonin agonist | |||
| 0.05 | 0.03 | 0.071 | Glucose-6-phosphate isomerase inhibitor | 0.071 0.012 CID_8375 | CID_8375 | |
| 0.035 | 0.015 | 0.041 | Uridine phosphorylase inhibitor | 0.041 0.011 CID_8375 | CID_8375 | |
| 0.042 | 0.022 | 0.042 | 5 Hydroxytryptamine 2B agonist | |||
| 0.069 | 0.05 | 0.071 | Amidase inhibitor | 0.071 0.048 CID_8375 | CID_8375 | |
| 0.024 | 0.006 | 0.024 | Alpha 2b adrenoreceptor agonist | 0.022 0.008 CID_8375 | ||
| 0.038 | 0.019 | 0.038 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.054 | 0.035 | 0.056 | Nicotinic alpha3beta2 receptor antagonist | 0.056 0.031 CID_8375 | CID_8375 | |
| 0.069 | 0.05 | 0.155 | HIV-1 integrase inhibitor | 0.155 0.008 CID_8375 | CID_8375 | |
| 0.051 | 0.033 | 0.051 | Potassium channel (Inward rectifier) activator | 0.051 0.034 CID_8375 | ||
| 0.047 | 0.03 | 0.059 | Adenylate cyclase 1 inhibitor | 0.059 0.019 CID_8375 | CID_8375 | |
| 0.051 | 0.033 | 0.059 | Squalene epoxidase inhibitor | 0.059 0.021 CID_8375 | CID_8375 | |
| 0.022 | 0.005 | 0.022 | Granulocyte colony stimulating factor receptor agonist | 0.019 0.01 CID_8375 | ||
| 0.042 | 0.025 | 0.099 | Dopamine D5 agonist | 0.099 0.004 CID_8375 | CID_8375 | |
| 0.048 | 0.032 | 0.073 | Glycine transporter 2 inhibitor | 0.073 0.02 CID_8375 | CID_8375 | |
| 0.057 | 0.042 | 0.067 | Lipocortins synthesis agonist | 0.067 0.025 CID_8375 | CID_8375 | |
| 0.035 | 0.02 | 0.039 | Liver X receptor beta agonist | 0.039 0.016 CID_8375 | CID_8375 | |
| 0.048 | 0.033 | 0.048 | Potassium channel (ATP-sensitive) activator | 0.048 0.033 CID_8375 | ||
| 0.039 | 0.024 | 0.053 | Glutamate (mGluR8) agonist | 0.053 0.01 CID_8375 | CID_8375 | |
| 0.034 | 0.02 | 0.06 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.06 0.008 CID_8375 | CID_8375 | |
| 0.018 | 0.004 | 0.018 | Progesterone receptor A antagonist | 0.017 0.004 CID_8375 | ||
| 0.09 | 0.076 | 0.105 | Phosphodiesterase 6D inhibitor | 0.105 0.043 CID_8375 | CID_8375 | |
| 0.032 | 0.018 | 0.032 | Elastase 3B inhibitor | |||
| 0.032 | 0.018 | 0.032 | Elastase 3A inhibitor | |||
| 0.032 | 0.018 | 0.032 | Elastase 2B inhibitor | |||
| 0.04 | 0.026 | 0.04 | Alpha 1d adrenoreceptor agonist | 0.039 0.027 CID_8375 | ||
| 0.123 | 0.11 | 0.137 | Thiol protease inhibitor | 0.137 0.084 CID_8375 | CID_8375 | |
| 0.037 | 0.024 | 0.05 | Glutamate (mGluR3) antagonist | 0.05 0.012 CID_8375 | CID_8375 | |
| 0.031 | 0.018 | 0.044 | Liver X receptor beta antagonist | 0.044 0.01 CID_8375 | CID_8375 | |
| 0.111 | 0.098 | 0.111 | Calcium channel blocker | |||
| 0.024 | 0.011 | 0.024 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.075 | 0.063 | 0.093 | Carbonic anhydrase VI inhibitor | 0.093 0.044 CID_8375 | CID_8375 | |
| 0.021 | 0.009 | 0.021 | Alpha 2c adrenoreceptor agonist | |||
| 0.052 | 0.04 | 0.094 | Acyl-CoA dehydrogenase inhibitor | 0.094 0.018 CID_8375 | CID_8375 | |
| 0.058 | 0.047 | 0.058 | Glutamate (mGluR) agonist | 0.057 0.048 CID_8375 | ||
| 0.074 | 0.062 | 0.074 | Acetylcholine nicotinic antagonist | |||
| 0.025 | 0.014 | 0.025 | 5 Hydroxytryptamine 4 agonist | |||
| 0.044 | 0.033 | 0.044 | Oleamide hydrolase inhibitor | 0.039 0.038 CID_8375 | ||
| 0.056 | 0.045 | 0.114 | Biliverdin reductase inhibitor | 0.114 0.015 CID_8375 | CID_8375 | |
| 0.062 | 0.051 | 0.062 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.015 | 0.005 | 0.015 | Melatonin 2 antagonist | |||
| 0.095 | 0.085 | 0.346 | Chelator | 0.346 0.008 CID_8375 | CID_8375 | |
| 0.05 | 0.04 | 0.05 | Vanilloid 2 antagonist | 0.049 0.045 CID_8375 | ||
| 0.033 | 0.024 | 0.033 | Free fatty acid receptor 1 antagonist | |||
| 0.047 | 0.037 | 0.056 | Dopamine beta hydroxylase inhibitor | 0.056 0.02 CID_8375 | CID_8375 | |
| 0.024 | 0.014 | 0.048 | Prostaglandin F2 alpha agonist | 0.048 0.004 CID_8375 | CID_8375 | |
| 0.022 | 0.013 | 0.022 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.14 | 0.131 | 0.14 | I kappa B kinase epsilon inhibitor | |||
| 0.061 | 0.053 | 0.061 | Neuronal nicotinic receptor antagonist | |||
| 0.2 | 0.192 | 0.2 | Ca(v)3.3 blocker | |||
| 0.042 | 0.034 | 0.047 | Glutamate (mGluR group III) antagonist | 0.047 0.024 CID_8375 | CID_8375 | |
| 0.066 | 0.059 | 0.11 | Aminopeptidase I inhibitor | 0.11 0.023 CID_8375 | CID_8375 | |
| 0.015 | 0.008 | 0.015 | Melatonin receptor 1A antagonist | |||
| 0.078 | 0.071 | 0.095 | CC chemokine 5 receptor agonist | 0.095 0.028 CID_8375 | CID_8375 | |
| 0.03 | 0.023 | 0.03 | Cholesterol ester transfer protein antagonist | |||
| 0.028 | 0.021 | 0.045 | Estrogen-related receptor gamma antagonist | 0.045 0.004 CID_8375 | CID_8375 | |
| 0.077 | 0.07 | 0.077 | GABA A receptor agonist | 0.075 0.073 CID_8375 | ||
| 0.052 | 0.045 | 0.085 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.085 0.018 CID_8375 | CID_8375 | |
| 0.029 | 0.022 | 0.029 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.026 | 0.019 | 0.034 | Sodium/glucose cotransporter 2 inhibitor | 0.034 0.01 CID_8375 | CID_8375 | |
| 0.033 | 0.027 | 0.039 | Phosphoglycerate kinase inhibitor | 0.039 0.02 CID_8375 | CID_8375 | |
| 0.086 | 0.08 | 0.086 | Alpha 2c adrenoreceptor antagonist | |||
| 0.042 | 0.036 | 0.042 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.02 | 0.015 | 0.02 | Imidazoline I1 receptor antagonist | |||
| 0.034 | 0.029 | 0.051 | 5-Alpha-reductase inhibitor | 0.051 0.018 CID_8375 | CID_8375 | |
| 0.067 | 0.062 | 0.126 | Glutamate dehydrogenase inhibitor | 0.126 0.021 CID_8375 | CID_8375 | |
| 0.061 | 0.056 | 0.163 | Phosphofructokinase-1 inhibitor | 0.163 0.016 CID_8375 | CID_8375 | |
| 0.032 | 0.027 | 0.048 | Fumarate hydratase inhibitor | 0.048 0.014 CID_8375 | CID_8375 | |
| 0.05 | 0.045 | 0.05 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.061 | 0.056 | 0.195 | Phenylalanine 4-hydroxylase inhibitor | 0.195 0.007 CID_8375 | CID_8375 | |
| 0.049 | 0.045 | 0.067 | Alpha-mannosidase inhibitor | 0.067 0.02 CID_8375 | CID_8375 | |
| 0.06 | 0.056 | 0.06 | Kallikrein 7 inhibitor | |||
| 0.013 | 0.01 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.006 CID_8375 | CID_8375 | |
| 0.063 | 0.06 | 0.063 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.056 | 0.053 | 0.08 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.08 0.019 CID_8375 | CID_8375 | |
| 0.091 | 0.088 | 0.102 | 5 Hydroxytryptamine 3A agonist | 0.102 0.074 CID_8375 | CID_8375 | |
| 0.047 | 0.045 | 0.047 | GABA A receptor antagonist | |||
| 0.013 | 0.011 | 0.013 | Cyclin D2 inhibitor | 0.013 0.01 CID_8375 | ||
| 0.081 | 0.08 | 0.153 | Aminopeptidase B inhibitor | 0.153 0.036 CID_8375 | CID_8375 | |
| 0.024 | 0.023 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 CID_8375 | CID_8375 | |
| 0.056 | 0.055 | 0.073 | Dopamine D1 antagonist | 0.073 0.038 CID_8375 | CID_8375 | |
| 0.126 | 0.126 | 0.131 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.131 0.114 CID_8375 | CID_8375 | |
| 0.011 | 0.011 | 0.021 | Calcium-dependent phospholipase A2 inhibitor | 0.021 0.004 CID_8375 | CID_8375 | |
| 0.032 | 0.032 | 0.034 | Calcium-independent phospholipase A2 inhibitor | 0.034 0.024 CID_8375 | CID_8375 | |
| 0.052 | 0.052 | 0.097 | Carbamoyl phosphate synthetase inhibitor | 0.097 0.022 CID_8375 | CID_8375 | |
| 0.065 | 0.067 | 0.114 | Topoisomerase II alpha inhibitor | 0.114 0.032 CID_8375 | CID_8375 | |
| 0.083 | 0.085 | 0.1 | Interleukin 1 beta converting enzyme inhibitor | 0.1 0.058 CID_8375 | CID_8375 | |
| 0.122 | 0.124 | 0.128 | Pregnane X receptor agonist | 0.128 0.105 CID_8375 | CID_8375 | |
| 0.074 | 0.078 | 0.093 | Myeloperoxidase inhibitor | 0.093 0.044 CID_8375 | CID_8375 | |
| 0.077 | 0.082 | 0.121 | Potassium channel activator | 0.121 0.032 CID_8375 | CID_8375 | |
| 0.016 | 0.021 | 0.021 | Progesterone receptor B antagonist | 0.021 0.012 CID_8375 | CID_8375 | |
| 0.032 | 0.038 | 0.062 | Urate transporter 1 inhibitor | 0.062 0.013 CID_8375 | CID_8375 | |
| 0.048 | 0.054 | 0.077 | Glucosylceramidase inhibitor | 0.077 0.017 CID_8375 | CID_8375 | |
| 0.036 | 0.042 | 0.046 | Glutamate (mGluR group III) agonist | 0.046 0.027 CID_8375 | CID_8375 | |
| 0.043 | 0.049 | 0.069 | Carbonic anhydrase IX inhibitor | 0.069 0.033 CID_8375 | CID_8375 | |
| 0.081 | 0.088 | 0.091 | Potassium channel (Voltage-sensitive) activator | 0.091 0.067 CID_8375 | CID_8375 | |
| 0.058 | 0.066 | 0.079 | Prostaglandin-E synthase inhibitor | 0.079 0.039 CID_8375 | CID_8375 | |
| 0.047 | 0.055 | 0.049 | Heparanase inhibitor | 0.049 0.048 CID_8375 | CID_8375 | |
| 0.021 | 0.03 | 0.032 | Vanilloid 2 agonist | 0.032 0.008 CID_8375 | CID_8375 | |
| 0.033 | 0.041 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.027 CID_8375 | CID_8375 | |
| 0.017 | 0.026 | 0.02 | Retinoid X beta receptor antagonist | 0.02 0.015 CID_8375 | CID_8375 | |
| 0.043 | 0.051 | 0.068 | Factor IXa inhibitor | 0.068 0.022 CID_8375 | CID_8375 | |
| 0.051 | 0.06 | 0.091 | Heat shock protein 90 beta antagonist | 0.091 0.014 CID_8375 | CID_8375 | |
| 0.039 | 0.049 | 0.049 | Carbonic anhydrase XIV inhibitor | 0.049 0.034 CID_8375 | CID_8375 | |
| 0.002 | 0.012 | 0.005 | Transcortin receptor antagonist | 0.005 0.004 CID_8375 | CID_8375 | |
| 0.027 | 0.037 | 0.036 | Retinoid X alpha receptor agonist | 0.036 0.023 CID_8375 | CID_8375 | |
| 0.028 | 0.039 | 0.036 | Glutamate (mGluR4) agonist | 0.036 0.02 CID_8375 | CID_8375 | |
| 0.067 | 0.078 | 0.075 | Interferon agonist | 0.075 0.061 CID_8375 | CID_8375 | |
| 0.056 | 0.068 | 0.073 | Beta 2 adrenoreceptor agonist | 0.073 0.015 CID_8375 | CID_8375 | |
| 0.035 | 0.047 | 0.056 | Geranyltranstransferase inhibitor | 0.056 0.017 CID_8375 | CID_8375 | |
| 0.027 | 0.039 | 0.033 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.033 0.025 CID_8375 | CID_8375 | |
| 0.04 | 0.052 | 0.086 | Aldose reductase inhibitor | 0.086 0.021 CID_8375 | CID_8375 | |
| 0.084 | 0.098 | 0.177 | Protein-tyrosine phosphatase 1B inhibitor | 0.177 0.036 CID_8375 | CID_8375 | |
| 0.017 | 0.031 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 CID_8375 | CID_8375 | |
| 0.049 | 0.063 | 0.177 | HIV-1 integrase (3'-Processing) inhibitor | 0.177 0.011 CID_8375 | CID_8375 | |
| 0.116 | 0.13 | 0.26 | Mcl-1 antagonist | 0.26 0.032 CID_8375 | CID_8375 | |
| 0.012 | 0.028 | 0.019 | Telomerase stimulant | 0.019 0.009 CID_8375 | CID_8375 | |
| 0.035 | 0.051 | 0.055 | Mannosidase inhibitor | 0.055 0.021 CID_8375 | CID_8375 | |
| 0.014 | 0.031 | 0.028 | Estrogen-related receptor gamma agonist | 0.028 0.004 CID_8375 | CID_8375 | |
| 0.022 | 0.04 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.019 CID_8375 | CID_8375 | |
| 0.029 | 0.047 | 0.04 | Dihydropteroate synthase inhibitor | 0.04 0.027 CID_8375 | CID_8375 | |
| 0.045 | 0.065 | 0.095 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.095 0.018 CID_8375 | CID_8375 | |
| 0.041 | 0.063 | 0.067 | CD45 antagonist | 0.067 0.016 CID_8375 | CID_8375 | |
| 0.055 | 0.077 | 0.093 | Antineoplastic antibiotic | 0.093 0.05 CID_8375 | CID_8375 | |
| 0.043 | 0.065 | 0.069 | Carbonic anhydrase inhibitor | 0.069 0.041 CID_8375 | CID_8375 | |
| 0.052 | 0.076 | 0.07 | Heme oxygenase stimulant | 0.07 0.025 CID_8375 | CID_8375 | |
| 0.02 | 0.045 | 0.031 | Retinoid X receptor agonist | 0.031 0.029 CID_8375 | CID_8375 | |
| 0.012 | 0.036 | 0.017 | Antibiotic Tetracycline-like | 0.017 0.007 CID_8375 | CID_8375 | |
| 0.014 | 0.039 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 CID_8375 | CID_8375 | |
| 0.035 | 0.061 | 0.05 | Beta 2 adrenoreceptor antagonist | 0.05 0.036 CID_8375 | CID_8375 | |
| 0.022 | 0.049 | 0.033 | ATP citrate lysase inhibitor | 0.033 0.02 CID_8375 | CID_8375 | |
| 0.08 | 0.107 | 0.109 | AMP-activated protein kinase stimulant | 0.109 0.059 CID_8375 | CID_8375 | |
| 0.042 | 0.07 | 0.055 | Sphingosine kinase 2 inhibitor | 0.055 0.039 CID_8375 | CID_8375 | |
| 0.013 | 0.042 | 0.02 | Glutamate (mGluR1a) agonist | 0.02 0.019 CID_8375 | CID_8375 | |
| 0.137 | 0.167 | 0.233 | Immunostimulant | 0.233 0.103 CID_8375 | CID_8375 | |
| 0.018 | 0.047 | 0.025 | Nicotinic acid receptor 2 antagonist | 0.025 0.021 CID_8375 | CID_8375 | |
| 0.029 | 0.059 | 0.042 | Carbonic anhydrase VII inhibitor | 0.042 0.038 CID_8375 | CID_8375 | |
| 0.037 | 0.069 | 0.061 | Topoisomerase II beta inhibitor | 0.061 0.022 CID_8375 | CID_8375 | |
| 0.079 | 0.111 | 0.147 | Topoisomerase II inhibitor | 0.147 0.051 CID_8375 | CID_8375 | |
| 0.028 | 0.06 | 0.057 | Carbonic anhydrase XII inhibitor | 0.057 0.034 CID_8375 | CID_8375 | |
| 0.071 | 0.103 | 0.08 | Vanilloid agonist | 0.08 0.07 CID_8375 | CID_8375 | |
| 0.028 | 0.06 | 0.044 | Adenosine deaminase inhibitor | 0.044 0.036 CID_8375 | CID_8375 | |
| 0.032 | 0.064 | 0.063 | Ornithine carbamoyltransferase inhibitor | 0.063 0.03 CID_8375 | CID_8375 | |
| 0.035 | 0.067 | 0.044 | Cholesterol esterase inhibitor | 0.044 0.04 CID_8375 | CID_8375 | |
| 0.026 | 0.058 | 0.05 | Oxytocin agonist | 0.05 0.024 CID_8375 | CID_8375 | |
| 0.042 | 0.075 | 0.069 | Androgen agonist | 0.069 0.031 CID_8375 | CID_8375 | |
| 0.104 | 0.137 | 0.225 | Protein-tyrosine phosphatase inhibitor | 0.225 0.038 CID_8375 | CID_8375 | |
| 0.025 | 0.059 | 0.033 | Ceramide glucosyltransferase inhibitor | 0.033 0.031 CID_8375 | CID_8375 | |
| 0.023 | 0.058 | 0.031 | RNA-directed RNA polymerase inhibitor | 0.031 0.029 CID_8375 | CID_8375 | |
| 0.033 | 0.069 | 0.047 | Glutamate (mGluR4) antagonist | 0.047 0.025 CID_8375 | CID_8375 | |
| 0.031 | 0.068 | 0.051 | Carbonic anhydrase VB inhibitor | 0.051 0.044 CID_8375 | CID_8375 | |
| 0.041 | 0.078 | 0.051 | Thromboxane synthase inhibitor | 0.051 0.045 CID_8375 | CID_8375 | |
| 0.066 | 0.103 | 0.085 | Bronchodilator | 0.085 0.08 CID_8375 | CID_8375 | |
| 0.054 | 0.093 | 0.073 | Phospholipase D inhibitor | 0.073 0.047 CID_8375 | CID_8375 | |
| 0.088 | 0.128 | 0.213 | Estrogen antagonist | 0.213 0.012 CID_8375 | CID_8375 | |
| 0.03 | 0.072 | 0.048 | Thromboxane antagonist | 0.048 0.043 CID_8375 | CID_8375 | |
| 0.06 | 0.102 | 0.079 | Vanilloid 4 agonist | 0.079 0.043 CID_8375 | CID_8375 | |
| 0.016 | 0.061 | 0.075 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.075 0.007 CID_8375 | CID_8375 | |
| 0.008 | 0.054 | 0.021 | Nicotinic acid receptor 1 antagonist | 0.021 0.008 CID_8375 | CID_8375 | |
| 0.078 | 0.124 | 0.1 | Acetylcholine muscarinic antagonist | 0.1 0.091 CID_8375 | CID_8375 | |
| 0.026 | 0.072 | 0.048 | Thromboxane A2 antagonist | 0.048 0.037 CID_8375 | CID_8375 | |
| 0.097 | 0.144 | 0.151 | Cell wall synthesis inhibitor | 0.151 0.065 CID_8375 | CID_8375 | |
| 0.077 | 0.125 | 0.112 | Protein kinase C gamma inhibitor | 0.112 0.06 CID_8375 | CID_8375 | |
| 0.024 | 0.073 | 0.037 | CDK5/p25 inhibitor | 0.037 0.033 CID_8375 | CID_8375 | |
| 0.043 | 0.095 | 0.067 | NMDA receptor agonist | 0.067 0.039 CID_8375 | CID_8375 | |
| 0.035 | 0.088 | 0.058 | NMDA receptor glycine site agonist | 0.058 0.047 CID_8375 | CID_8375 | |
| 0.016 | 0.069 | 0.031 | Thyroid hormone agonist | 0.031 0.012 CID_8375 | CID_8375 | |
| 0.101 | 0.16 | 0.222 | Dual specificity phosphatase 3 inhibitor | 0.222 0.05 CID_8375 | CID_8375 | |
| 0.031 | 0.091 | 0.043 | CF transmembrane conductance regulator antagonist | 0.043 0.018 CID_8375 | CID_8375 | |
| 0.027 | 0.088 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.046 0.03 CID_8375 | CID_8375 | |
| 0.044 | 0.105 | 0.091 | Neuraminidase (influenza) inhibitor | 0.091 0.019 CID_8375 | CID_8375 | |
| 0.067 | 0.13 | 0.091 | Protein kinase C zeta inhibitor | 0.091 0.063 CID_8375 | CID_8375 | |
| 0.037 | 0.101 | 0.099 | Lipase inhibitor | 0.099 0.028 CID_8375 | CID_8375 | |
| 0.067 | 0.132 | 0.191 | Estrogen receptor beta antagonist | 0.191 0.01 CID_8375 | CID_8375 | |
| 0.091 | 0.158 | 0.119 | Acetylcholine M1 receptor antagonist | 0.119 0.11 CID_8375 | CID_8375 | |
| 0.01 | 0.078 | 0.032 | CXC chemokine 2 receptor antagonist | 0.032 0.012 CID_8375 | CID_8375 | |
| 0.022 | 0.094 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.021 CID_8375 | CID_8375 | |
| 0.097 | 0.168 | 0.121 | Cyclin-dependent kinase 8 inhibitor | 0.121 0.117 CID_8375 | CID_8375 | |
| 0.03 | 0.104 | 0.078 | Neuraminidase inhibitor | 0.078 0.027 CID_8375 | CID_8375 | |
| 0.033 | 0.109 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.028 CID_8375 | CID_8375 | |
| 0.022 | 0.099 | 0.048 | NMDA receptor subunit 3B antagonist | 0.048 0.026 CID_8375 | CID_8375 | |
| 0.038 | 0.115 | 0.061 | Sphingosine kinase inhibitor | 0.061 0.037 CID_8375 | CID_8375 | |
| 0.015 | 0.093 | 0.045 | Catechol O-methyltransferase inhibitor | 0.045 0.011 CID_8375 | CID_8375 | |
| 0.081 | 0.159 | 0.117 | Interleukin 8 antagonist | 0.117 0.065 CID_8375 | CID_8375 | |
| 0.105 | 0.186 | 0.169 | Interleukin 6 antagonist | 0.169 0.065 CID_8375 | CID_8375 | |
| 0.042 | 0.126 | 0.073 | Histone deacetylase stimulant | 0.073 0.051 CID_8375 | CID_8375 | |
| 0.042 | 0.126 | 0.073 | Histone deacetylase SIRT1 stimulant | 0.073 0.051 CID_8375 | CID_8375 | |
| 0.023 | 0.109 | 0.038 | Sphingosine kinase 1 inhibitor | 0.038 0.036 CID_8375 | CID_8375 | |
| 0.098 | 0.188 | 0.201 | Dual specificity phosphatase inhibitor | 0.201 0.054 CID_8375 | CID_8375 | |
| 0.046 | 0.137 | 0.092 | Adrenaline agonist | 0.092 0.044 CID_8375 | CID_8375 | |
| 0.033 | 0.124 | 0.067 | Fatty acid synthase inhibitor | 0.067 0.028 CID_8375 | CID_8375 | |
| 0.015 | 0.107 | 0.038 | NMDA receptor subunit 3A antagonist | 0.038 0.027 CID_8375 | CID_8375 | |
| 0.094 | 0.192 | 0.136 | Amyloid beta precursor protein antagonist | 0.136 0.118 CID_8375 | CID_8375 | |
| 0.036 | 0.136 | 0.054 | DNA helicase inhibitor | 0.054 0.039 CID_8375 | CID_8375 | |
| 0.06 | 0.163 | 0.127 | Adenylate cyclase inhibitor | 0.127 0.062 CID_8375 | CID_8375 | |
| 0.012 | 0.117 | 0.099 | Estrogen agonist | 0.099 0.017 CID_8375 | CID_8375 | |
| 0.034 | 0.141 | 0.06 | CDC25B inhibitor | 0.06 0.051 CID_8375 | CID_8375 | |
| 0.052 | 0.161 | 0.1 | Uric acid excretion stimulant | 0.1 0.053 CID_8375 | CID_8375 | |
| 0.004 | 0.114 | 0.085 | Estrogen receptor alpha agonist | 0.085 0.011 CID_8375 | CID_8375 | |
| 0.031 | 0.14 | 0.055 | Botulinum neurotoxin type A inhibitor | 0.055 0.047 CID_8375 | CID_8375 | |
| 0.015 | 0.126 | 0.059 | NMDA 2A receptor antagonist | 0.059 0.03 CID_8375 | CID_8375 | |
| 0.006 | 0.125 | 0.018 | Thyroid hormone alpha antagonist | 0.018 0.009 CID_8375 | CID_8375 | |
| 0.017 | 0.141 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.017 CID_8375 | CID_8375 | |
| 0.047 | 0.173 | 0.184 | M18 aspartyl aminopeptidase inhibitor | 0.184 0.038 CID_8375 | CID_8375 | |
| 0.203 | 0.329 | 0.405 | Antiinflammatory | 0.405 0.136 CID_8375 | CID_8375 | |
| 0.039 | 0.165 | 0.072 | CDC25A inhibitor | 0.072 0.054 CID_8375 | CID_8375 | |
| 0.005 | 0.136 | 0.085 | Estrogen receptor beta agonist | 0.085 0.014 CID_8375 | CID_8375 | |
| 0.039 | 0.176 | 0.087 | Topoisomerase I inhibitor | 0.087 0.082 CID_8375 | CID_8375 | |
| 0.029 | 0.167 | 0.067 | Protein kinase C beta inhibitor | 0.067 0.054 CID_8375 | CID_8375 | |
| 0.018 | 0.185 | 0.088 | Maillard reaction inhibitor | 0.088 0.021 CID_8375 | CID_8375 | |
| 0.028 | 0.218 | 0.078 | NMDA receptor antagonist | 0.078 0.068 CID_8375 | CID_8375 | |
| 0.069 | 0.289 | 0.134 | NOS3 expression enhancer | 0.134 0.092 CID_8375 | CID_8375 | |
| 0.005 | 0.232 | 0.017 | Thyroid hormone alpha agonist | 0.017 0.01 CID_8375 | CID_8375 | |
| 0.066 | 0.33 | 0.171 | Growth hormone agonist | 0.171 0.072 CID_8375 | CID_8375 | |
| 0.021 | 0.297 | 0.055 | CXC chemokine 1 receptor antagonist | 0.055 0.028 CID_8375 | CID_8375 | |
| 0.036 | 0.342 | 0.095 | DNA polymerase I inhibitor | 0.095 0.092 CID_8375 | CID_8375 | |
| 0.043 | 0.402 | 0.085 | Hematopoietic | 0.085 0.059 CID_8375 | CID_8375 | |
| 0.087 | 0.448 | 0.127 | CC chemokine 6 receptor antagonist | 0.127 0.081 CID_8375 | CID_8375 | |
| 0.089 | 0.514 | 0.172 | Peptidyltransferase inhibitor | 0.172 0.142 CID_8375 | CID_8375 | |
| 0.066 | 0.534 | 0.144 | Catenin beta inhibitor | 0.144 0.12 CID_8375 | CID_8375 | |
| 0.076 | 0.62 | 0.278 | Interleukin 2 agonist | 0.278 0.091 CID_8375 | CID_8375 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |